Literature DB >> 10753709

The N-terminal matrix domain of HIV-1 Gag is sufficient but not necessary for viral protein U-mediated enhancement of particle release through a membrane-targeting mechanism.

A Deora1, P Spearman, L Ratner.   

Abstract

Viral protein U (Vpu) is an 81 amino acid phosphoprotein found in human immunodeficiency virus type 1 (HIV-1)-infected cells. One function of Vpu is to enhance the release of virus particles from the plasma membrane in infected cells. Using subcellular fractionation, we observed that Vpu promotes the targeting of Pr55 Gag to the plasma membrane, the site of viral assembly. Deletions of Pr55, which removed most of the N-terminal matrix domain (p39) or the C-terminal domains of nucleocapsid and p6 (p41), still allowed for virus-like particle production. Moreover, the release of these particles remained Vpu-responsive. The N-terminal matrix (MA) domain of Gag, which contains its membrane-binding domain, is sufficient for Vpu-mediated enhanced release into the supernatant. Furthermore, a MA-GFP fusion protein showed enhanced membrane binding in the presence of Vpu. This demonstrates that Vpu action may be mediated by allowing Gag, specifically the N-terminal matrix domain, to efficiently associate with the plasma membrane. Thus MA appears sufficient but not necessary for Vpu-mediated enhanced particle release. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10753709     DOI: 10.1006/viro.1999.0094

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  8 in total

1.  Viral protein U (Vpu)-mediated enhancement of human immunodeficiency virus type 1 particle release depends on the rate of cellular proliferation.

Authors:  A Deora; L Ratner
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

2.  Molecular dynamics simulations on the first two helices of Vpu from HIV-1.

Authors:  I Sramala; V Lemaitre; J D Faraldo-Gómez; S Vincent; A Watts; W B Fischer
Journal:  Biophys J       Date:  2003-05       Impact factor: 4.033

3.  Vpu and Tsg101 regulate intracellular targeting of the human immunodeficiency virus type 1 core protein precursor Pr55gag.

Authors:  Kirsi Harila; Ian Prior; Mathilda Sjöberg; Antti Salminen; Jorma Hinkula; Maarit Suomalainen
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

Review 4.  HIV Genome-Wide Protein Associations: a Review of 30 Years of Research.

Authors:  Guangdi Li; Erik De Clercq
Journal:  Microbiol Mol Biol Rev       Date:  2016-06-29       Impact factor: 11.056

5.  HIV-1 Vpu promotes release and prevents endocytosis of nascent retrovirus particles from the plasma membrane.

Authors:  Stuart J D Neil; Scott W Eastman; Nolwenn Jouvenet; Paul D Bieniasz
Journal:  PLoS Pathog       Date:  2006-05-12       Impact factor: 6.823

6.  SARS coronavirus E protein forms cation-selective ion channels.

Authors:  Lauren Wilson; Carolyn McKinlay; Peter Gage; Gary Ewart
Journal:  Virology       Date:  2004-12-05       Impact factor: 3.616

7.  Evidence that Vpu modulates HIV-1 Gag-envelope interaction towards envelope incorporation and infectivity in a cell type dependent manner.

Authors:  Archana Gautam; Jayanta Bhattacharya
Journal:  PLoS One       Date:  2013-04-16       Impact factor: 3.240

8.  Molecular characterization of HIV-1 genome in fission yeast Schizosaccharomyces pombe.

Authors:  Joseph Nkeze; Lin Li; Zsigmond Benko; Ge Li; Richard Y Zhao
Journal:  Cell Biosci       Date:  2015-08-25       Impact factor: 7.133

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.